Belden Inc. (BDC)
| Previous Close | 94.88 |
| Open | 94.78 |
| Bid | 95.91 x 1000 |
| Ask | 96.03 x 800 |
| Day's Range | 94.73 - 96.07 |
| 52 Week Range | 60.55 - 99.13 |
| Volume | |
| Avg. Volume | 258,827 |
| Market Cap | 3.902B |
| Beta (5Y Monthly) | 1.07 |
| PE Ratio (TTM) | 18.77 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.20 (0.21%) |
| Ex-Dividend Date | Mar 13, 2024 |
| 1y Target Est | N/A |
- PR Newswire
Infinant Health Appoints New Team Members to assist with Drug Development
Infinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the immune system via the gut microbiome, announces additions to their advisory team: Dr. Katharine Knobil and Dr. David Pompliano. Additionally, Judy Gawlik Brown has joined the board, representing Manna Tree Partners, to help prepare the company's expansion into pharma.
- Business Wire
Belden’s New Fiber Technology Center Enables Continued Fiber Leadership and Innovation
ST. LOUIS, May 15, 2024--Belden, a leading global supplier of network infrastructure and digitization solutions, is excited to announce the opening today of a new state-of-the-art Fiber Technology Center in Tucson, AZ, which will enable continued leadership in and commitment to optical fiber, as digital transformation accelerates demand for the bandwidth fiber offers.
- Business Wire
Belden Names 3 Finalists for Joseph C. Belden Innovation Award
ST. LOUIS, May 14, 2024--Belden Inc. (NYSE: BDC), a leading global supplier of network infrastructure and digitization solutions, is happy to announce that three companies have been selected as finalists for the inaugural Joseph C. Belden Innovation Award.
